[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$slrn
$SLRN engagements are up, but sentiment is mixed. Concerns about short theses are being raised, potentially leading to market volatility.
About $slrn
A cryptocurrency.
Insights #
- $slrn engagements is up XXXXX% from the previous week.
Engagements: XXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
1 Week: XXX +22%
1 Month: XXX -XX%
1-Year High: XXXXX on 2025-05-16
1-Year Low: X on 2025-09-07
| Social Network | X |
|---|---|
| Engagements | XXX |
Mentions: X #
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1 Month: X no change
1-Year High: XX on 2025-05-16
1-Year Low: X on 2025-07-15
| Social Network | X |
|---|---|
| Mentions | X |
Creators: X #
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $slrn in the last XX hours which is up XXX% from X in the previous XX hours
Daily Average: X
1 Month: X +50%
1-Year High: XX on 2025-05-07
1-Year Low: X on 2025-07-01
Top assets mentioned In the posts about $slrn in the last XX hours
10x Genomics, Inc. Class A Common Stock (TXG) Magic Eden (ME) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)
Top topics mentioned In the posts about $slrn in the last XX hours
$txg, $atnf, magic eden, coins solana ecosystem, coins nft, $mltx, $ifrx, rates, pumping
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"This is so well put @ProfitGrand Thank you $TXG $ATNF $ME $TSVT $FDMT $SXTP $ETNB $AADI $AARD $ABCL $ABEO $ABSI $ABVC $ACIU $AXDX $SLRN $ACHV $ACHL $ACRS $ACRV $ACTU $ABOS $ACXP $ADAG $ACET $ADTX $ANL $ADVM $AVTE $AFMD $AGEN $AIMD $AKTX $AKBA $AKYA $TCRT $ALDX"
X Link @BuyTheUgly 2025-10-14T16:25Z XX followers, XXX engagements
"My $MLTX short thesis wasn't clever but hinged on 1) HS studies produce idiosyncratic placebo response e.g $SLRN Izokibep 'bump' at wk XX vs wk16 $IFRX prior C5a 'high' placebo rates at P2b. 2) HiSCR endpoint variability. 3) Bim data v. high bar to clear 4) Management pumping"
X Link @BiotechSho99376 2025-09-29T10:19Z XXX followers, XXX engagements